Amicus Therapeutics vs Regenxbio
Amicus Therapeutics vs Regenxbio, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Amicus Therapeutics is on 57/100 and Regenxbio on 55/100.
Where each one leads
Amicus Therapeutics
- domain rating: 66/100 against 54/100
- headcount: 625 against 396
Regenxbio
- agent readiness: 36/100 against 21/100
At a glance
| Measure | Amicus Therapeutics | Regenxbio |
|---|---|---|
| What it is | Biotechnology company focused on developing treatments for rare metabolic diseases. | Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotech | Software |
| Founded | 2002 | 2008 |
| Headquarters | Philadelphia, United States | Rockville, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Amicus Therapeutics | Regenxbio |
|---|---|---|
| Employees | 625 | 396 |
| Total funding | $200M | $180M |
| Latest round | Series D | Funding Round |
| LinkedIn followers | 57,431 | 49,536 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Amicus Therapeutics | Regenxbio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 57/100 | 55/100 |
| Traction | 60/100 | 60/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 34/100 | 24/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 66/100 | 54/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Amicus Therapeutics | Regenxbio |
|---|---|---|
| Frameworks | Not detected | Bootstrap |
| Analytics | Not detected | Google Tag Manager |
Amicus Therapeutics vs Regenxbio: common questions
Which is better, Amicus Therapeutics or Regenxbio?
On our 0-100 score Amicus Therapeutics rates higher (57/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Amicus Therapeutics and Regenxbio compare on the numbers?
Amicus Therapeutics leads on domain rating (66/100 against 54/100), headcount (625 against 396). Regenxbio leads on agent readiness (36/100 against 21/100).
Read the full Amicus Therapeutics review and pricing or the Regenxbio review and pricing. You can also browse other Amicus Therapeutics alternatives we track.